Eledon Pharmaceuticals, Inc.ELDNNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+28.3%
5Y CAGR+44.8%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+28.3%/yr
vs +29.4%/yr prior
5Y CAGR
+44.8%/yr
Recent deceleration
Acceleration
-1.1pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
6.4x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $83.25M | +18.6% |
| 2024 | $70.22M | +64.7% |
| 2023 | $42.63M | +8.2% |
| 2022 | $39.41M | +7.5% |
| 2021 | $36.67M | +179.9% |
| 2020 | $13.10M | -6.4% |
| 2019 | $14.00M | -0.4% |
| 2018 | $14.06M | +7.2% |
| 2017 | $13.12M | -65.6% |
| 2016 | $38.12M | - |